memantine has been researched along with Eye Diseases in 3 studies
Eye Diseases: Diseases affecting the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Data on several compounds that achieve therapeutic posterior segment concentrations after topical dosing is presented." | 2.43 | Topical and systemic drug delivery to the posterior segments. ( Chang-Lin, JE; Hughes, PM; Olejnik, O; Wilson, CG, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, PM | 1 |
| Olejnik, O | 1 |
| Chang-Lin, JE | 1 |
| Wilson, CG | 1 |
| Lagrèze, WA | 1 |
| Pop, E | 1 |
1 review available for memantine and Eye Diseases
| Article | Year |
|---|---|
Topical and systemic drug delivery to the posterior segments.
Topics: Administration, Topical; Drug Administration Routes; Eye; Eye Diseases; Humans; Memantine; Models, B | 2005 |
2 other studies available for memantine and Eye Diseases
| Article | Year |
|---|---|
[Neuroprotection. Bases and possibilities of a future clinical use].
Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disea | 2001 |
Trends in neuroprotection.
Topics: Aged; Amlodipine; Animals; Antiparkinson Agents; Apoptosis; Brain Diseases; Calcium Channel Blockers | 2002 |